General information | Literature | Expression | Regulation | Variant | Interaction |
Basic Information |
|
---|---|
Gene ID | 1029 |
Name | CDKN2A |
Synonymous | ARF|CDK4I|CDKN2|CMM2|INK4|INK4A|MLM|MTS-1|MTS1|P14|P14ARF|P16|P16-INK4A|P16INK4|P16INK4A|P19|P19ARF|TP16;cyclin-dependent kinase inhibitor 2A;CDKN2A;cyclin-dependent kinase inhibitor 2A |
Definition | CDK4 inhibitor p16-INK4|cell cycle negative regulator beta|cyclin-dependent kinase 4 inhibitor A|cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)|multiple tumor suppressor 1 |
Position | 9p21 |
Gene Type | protein-coding |
Gene Expression: | TCGA pan-cancer expression Human Primary Tumor Samples (U95) Human U133A/GNF1H Gene Atlas |
TCGA pan-cancer expression summary | | Top | |
Precomputed P-values for average expression difference between tumor and normal samples in pan-cancer | ||
---|---|---|
BLCA: 2.1954215275123e-05 | BRCA: 1.22275159715583e-33 | COAD: 1.95503730535887e-20 |
HNSC: 3.46811788720689e-06 | KICH: 1.35059836452576e-16 | KIRC: 3.34331560985355e-52 |
LUAD: 1.1324480150868e-34 | LUSC: 1.33638091414349e-35 | PRAD: 2.00938523002281e-10 |
THCA: 9.87109428261265e-24 | UCEC: 2.5530511755414e-13 |
Human Primary Tumor Samples (U95) | | Top | |
Human U133A/GNF1H Gene Atlas | | Top | |